Citation Impact
Citing Papers
Adverse Cardiovascular Effects of the Coxibs
2005
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
2007
Copper-free click chemistry in living animals
2010 StandoutNobel
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Thermodynamic Parameters for the Association of Fluorinated Benzenesulfonamides with Bovine Carbonic Anhydrase II
2006
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II ‘selective’ inhibitor celecoxib
2005
Ligand-directed tosyl chemistry for protein labeling in vivo
2009
A “one-pot” multicomponent approach to polysubstituted 4-aminopyridines
2012
Integrin Structure, Activation, and Interactions
2011
Towards mild metal-catalyzed C–H bond activation
2011 Standout
Synthesis of functionally graded MgCO3 apatite accelerating osteoblast adhesion
2002
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Carbonic anhydrase inhibitors: Inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides—Solution and crystallographic studies
2007
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
2008 Standout
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
2012 Standout
Magnesium and its alloys as orthopedic biomaterials: A review
2005 Standout
Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors
2003
Anti-Inflammatory Drugs in the 21st Century
2007
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Integrins in prostate cancer progression
2008
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I–XIV with a series of natural product polyphenols and phenolic acids
2010
Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I–XIV)
2008
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
2012 StandoutNatureNobel
Platelet Activation and Atherothrombosis
2007 Standout
Mechanistic Considerations in the Development and Use of Azine, Diazine and Azole N-Oxides in Palladium-Catalyzed Direct Arylation
2009
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Carbonic anhydrase inhibitors: Design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes
2008
Carbonic anhydrase IX: A new druggable target for the design of antitumor agents
2007
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer
2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
2004
Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides
2004
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II
2006
Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines
2010
Protein Kinase A-mediated Phosphorylation of Serine 357 of the Mouse Prostacyclin Receptor Regulates Its Coupling to Gs-, to Gi-, and to Gq-coupled Effector Signaling
2001
Direct transition metal-catalyzed functionalization of heteroaromatic compounds
2007 Standout
Eicosanoids and cancer
2010 Standout
Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides
2006
Microenvironmental regulation of metastasis
2008 Standout
Targeting tumor–stromal interactions in bone metastasis
2013
Dynamic Combinatorial Chemistry Employing Boronic Acids/Boronate Esters Leads to Potent Oxygenase Inhibitors
2012 StandoutNobel
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
2007
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Seven-transmembrane receptors
2002 StandoutNobel
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Carbonic anhydrase inhibitors: Inhibition of mammalian isoforms I–XIV with a series of substituted phenols including paracetamol and salicylic acid
2008
Modulation of prostate cancer growth in bone microenvironments
2003
Catalytic CC, CN, and CO Ullmann‐Type Coupling Reactions
2009 Standout
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
2004
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
2006
Protein Kinase A-mediated Phosphorylation of the β2-Adrenergic Receptor Regulates Its Coupling to Gs and Gi
2002 StandoutNobel
Beyond Directing Groups: Transition‐Metal‐Catalyzed CH Activation of Simple Arenes
2012 Standout
Quantifying critical states of complex diseases using single-sample dynamic network biomarkers
2017
Direction of actin flow dictates integrin LFA-1 orientation during leukocyte migration
2017 StandoutNobel
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Thromboxane A2 Receptors in Prostate Carcinoma: Expression and Its Role in Regulating Cell Motility via Small GTPase Rho
2008
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Direct screening of a dynamic combinatorial library using mass spectrometry
2006
Efficient and highly regioselective direct C-2 arylation of azoles, including free (NH)-imidazole, -benzimidazole and -indole, with aryl halides
2006
Carbonic Anhydrase Inhibitors: Hypoxia-Activatable Sulfonamides Incorporating Disulfide Bonds that Target the Tumor-Associated Isoform IX
2006
The Silicon–Hydrogen Exchange Reaction: A Catalytic σ-Bond Metathesis Approach to the Enantioselective Synthesis of Enol Silanes
2020 StandoutNobel
Synthesis of Pyridine and Dihydropyridine Derivatives by Regio- and Stereoselective Addition toN-Activated Pyridines
2012 Standout
Fluorescent chemosensors: the past, present and future
2017 Standout
Palladium-Catalyzed Direct Arylation of Azine and Azole N-Oxides: Reaction Development, Scope and Applications in Synthesis
2009
Regiocontrolled Synthesis of 1,2‐Diaryl‐1H‐imidazoles by Palladium‐ and Copper‐Mediated Direct Coupling of 1‐Aryl‐1H‐imidazoles with Aryl Halides under Ligandless Conditions
2005
Carbonic Anhydrase Inhibitors. The Mitochondrial Isozyme VB as a New Target for Sulfonamide and Sulfamate Inhibitors
2005
Carboxylate-Assisted Transition-Metal-Catalyzed C−H Bond Functionalizations: Mechanism and Scope
2011 Standout
Carbonic Anhydrase Inhibitors. DNA Cloning, Characterization, and Inhibition Studies of the Human Secretory Isoform VI, a New Target for Sulfonamide and Sulfamate Inhibitors
2006
Oxidative Stress and Diabetic Complications
2010 Standout
Quenched Ligand-Directed Tosylate Reagents for One-Step Construction of Turn-On Fluorescent Biosensors
2009
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
A carbohydrate approach for the formal total synthesis of the prostacyclin analogue (16S)-iloprost
2012
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Adventures in vascular biology: a tale of two mediators
2006
Carbonic anhydrase inhibitors and activators and their use in therapy
2006
Cu-Catalyzed N- and O-Arylation of 2-, 3-, and 4-Hydroxypyridines and Hydroxyquinolines
2007
Endothelial cell activation by endotoxin involves superoxide/NO‐mediated nitration of prostacyclin synthase and thromboxane receptor stimulation
2003
Metal–Organic Frameworks in Biomedicine
2011 Standout
Prostaglandin I2(epoprostenol) triggers migraine-like attacks in migraineurs
2009
Role of Monocytes in Atherogenesis
2003
Rhodium-Catalyzed C−C Bond Formation via Heteroatom-Directed C−H Bond Activation
2009 Standout
Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions
2006 Standout
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry
2020 StandoutNobel
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Carbonic Anhydrase Inhibitors: DNA Cloning and Inhibition Studies of the α-Carbonic Anhydrase from Helicobacter pylori, A New Target for Developing Sulfonamide and Sulfamate Gastric Drugs
2006
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Xavier de Leval being referenced
Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2
2004
New Developments on Thromboxane and Prostacyclin Modulators Part I: Thromboxane Modulators
2004
Recent Advances in Antiplatelet Agents
2002
Activation of the Thromboxane A2 Pathway in Human Prostate Cancer Correlates with Tumor Gleason Score and Pathologic Stage
2006
New Trends in Thromboxane and Prostacyclin Modulators
2000
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood
2001
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
2003
Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition.
2000
Progress in the Field of GPIIb/IIIa Antagonists
2004
New Trends in Dual 5-LOX / COX Inhibition
2002
Advances in the field of COX-2 inhibition
2002
Therapeutic potential of thromboxane inhibitors in asthma
2002
Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers
2000
Design, Synthesis, and Pharmacological Evaluation of Pyridinic Analogues of Nimesulide as Cyclooxygenase-2 Selective Inhibitors
2004
Spectral and Crystallographic Study of Pyridinic Analogues of Nimesulide: Determination of the Active Form of Methanesulfonamides as COX-2 Selective Inhibitors
2002
Pyridine Analogues of Nimesulide: Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors
2009
Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition.
2000
Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of Cytosolic/Membrane-Associated Carbonic Anhydrase Isozymes I, II, and IX with Sulfonamides Incorporating Hydrazino Moieties
2004
New Developments on Thromboxane and Prostacyclin Modulators Part II: Prostacyclin Modulators
2004
Carbonic Anhydrase Inhibitors: Synthesis and Topical Intraocular Pressure Lowering Effects of Fluorine-Containing Inhibitors Devoid of Enhanced Reactivity
2004